Skin and Soft Tissue Infections (SSTI) and Wound Care in the Age of Xylazine

Event sold-out

Virtual meeting

Via Zoom

Description

This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of skin wounds with chronic exposure. We will discuss how these wounds may present themselves among those using substances with xylazine, harm reduction best practices, and ways they are currently being treated in hospital and community settings. We will have multiple harm reductionists and wound care providers share their experiences and discuss best practices and treatment protocols they have been using with their patients with skin wounds and some of the current clinical challenges in outpatient management.

PLEASE NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which does not count for CEUs.

Intended audience

Providers, nurses, counselors, and other non-clinical staff are welcome to attend.

Speakers

Rebecca Hosey RN, BSN, MPH

Ms. Hosey is a nurse, public health consultant, and family member of people in recovery in Philadelphia, PA, USA. She currently attends the University of Pennsylvania School of Nursing studying to become a Family Nurse Practitioner. She has worked for Prevention Point Philadelphia and other public health organizations in direct service in drop-in centers and HIV clinics, as well as behind the scenes working on policy and program evaluation. She is currently practicing as a registered nurse in clinical research, wound care, abortion care, and also works as a research assistant.

Raagini Jawa, MD, MPH

Dr. Jawa is an Assistant Professor and Clinician Investigator in the Department of General Internal Medicine at University of Pittsburgh Medical Center and a clinician investigator in the Center for Research on Health Care. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa’s research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions so as to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends on the Endovascular Infection Service at UPMC.

Stephanie Klipp RN, CARN, CRS

Ms. Klipp is a board certified addiction's registered nurse from Philadelphia, Pennsylvania. She is also certified through the Pennsylvania Certification Board as an Alllied Addiction Practioner (CAAP), and a Certified Recovery Specialist (CRS). Stephanie currently works as a Harm Reduction Outreach Nurse at Courage Medicine, where she offers low barrier buprenorphine and wound care. She is a community adovcate and educator around supporting individuals who use or inject drugs, with a focus on reducing stigma and promoting overall wellness. Stephanie has worked within addiction medicine programs to operationalize inpatient addiction consult services, and outpatient clinics for the treatment of opioid use disorders. She obtained her undergraduate nursing education at Pennsylvania State University, and is currently persuing her FNP in nursing. Stephanie also serves as a member on the Board of Directors of PNAP, the Pennsylvania Nurse Peer Assistance Program. As a preivous graduate of the program, she works to help mentor and adovcate for nurses impacted or suffering from addiction. She educates within various health systems, nurse residency programs, and nursing schools on implemention of harm reduction principles into clinical practice. Stephanie's interest are around nursing interventions and education that can be implemented in a health care setting to help create improved outcomes for patients with substance use disorders, across the health care spectrum.

Stephen Murray, MPH, NRP

Stephen is an overdose researcher at Boston Medical Center, focusing on the role of public safety/public health partnerships in post-overdose response teams. He recently retired as a Lieutenant at a regional ambulance service in Western Massachusetts, and had served as a first responder since 2013, working both as a firefighter and paramedic. He shares his lived experience as a person who used drugs and as an overdose survivor. Stephen provides expert technical assistance around the topics of overdose prevention, emergency medical services, and harm reduction to a variety of organizations, including the Berkshire Regional Planning Commission, Substance Abuse and Mental Health Services Administration (SAMHSA), the City of Northampton, RIZE Foundation, Massachusetts Drug Supply Data Stream, and the Massachusetts Department of Public Health. He has guest lectured at Northeastern University, UMASS Medical School, Bennington College, Boston University, and Ohio State University, and has had work published in the American Journal of Public Health and Health Promotion Practice.

Mary Wheeler

Mary began in harm reduction in 1999 as a volunteer outreach worker for the Massachusetts Helpline and JRI Health in Boston. Since that time, Mary has worked at the Boston and Cambridge Syringe Exchange Programs and came to Lynn, MA in 2005 to work at Healthy Streets. Mary is currently the Program Director at Healthy Streets Outreach Program in Lynn, MA where she has worked for over ten years. Healthy Streets provides harm services and operates two syringe service programs, and has expanded services to include people who use non-injection drugs. Mary is also the executive director of a newly formed organization, Not One More Anonymous Death Inc. (NOMAD).

Objectives

Following this training, participants will have the knowledge necessary to:

Identify common skin and soft tissue manifestations associated with xylazine use.
Describe harm reduction practices to decrease risk of skin wounds in persons using xylazine.
List 2 agents for wound care for persons using Xylazine.

Accreditation information

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete and return the evaluation and stay for the entire session will be awarded 1.00 contact hours

The lecture has been approved by The Network of Professional Education at Boston University School of Social Work, accredited by the Commonwealth of Massachusetts Board of Social Work Registration, to provide 1.00 credit hours.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.